A range of lung diseases, including idiopathic pulmonary fibrosis, COPD, and asthma have been associated with loss of E-cadherin function and elevated sE-cad levels (Yuksel et al., 2021; Mottais et al., 2023). Here, CDH1 is linked to lung disorder.